Related Experiment Video
Updated: Jun 19, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Rationale for Preservative-free Glaucoma Drops
1Department of Ophthalmology, University of Washington, Seattle, WA.
Abstract:
Benzalkonium chloride (BAK) is the most widely used preservative in multidose glaucoma eye drops. Medical management of glaucoma often requires the chronic use of preserved eye drops, resulting in a high incidence of BAK‑associated ocular discomfort, ocular surface disease, accumulation within ocular structures, and inflammatory tissue changes. The use of BAK has also been associated with reduced surgical success in trabeculectomy. Although alternative preservatives exist, they have also been associated with some toxic effects. Switching from BAK‑containing formulations to preservative‑free (PF) formulations results in significantly fewer side effects, improved ocular surface disease, and enhanced patient comfort. However, barriers such as cost and ease of use have impeded the more widespread adoption of PF glaucoma drops.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
